Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm

被引:19
作者
De Vry, J [1 ]
Jentzsch, KR [1 ]
机构
[1] Bayer HealthCare, CNS Res, Wuppertal, Germany
来源
BEHAVIOURAL PHARMACOLOGY | 2004年 / 15卷 / 01期
关键词
CP 55,940; rat; SR141716A; Delta(9)-tetrahydrocannabinol; WIN 55,212-2;
D O I
10.1097/00008877-200402000-00002
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Both cannabinoid CB, receptor agonists, such as Delta(9)-tetrahydrocannabinol (Delta(9)-THC), CP 55,940 and WIN 55,212-2, and the antagonist/inverse agonist SR141716A, dose-dependently suppress operant behavior. The present study investigated to what extent combined i.p. application of SR141716A with these cannabinoids resulted in mutually antagonistic effects, in additive effects, or in no interactive effects on operant responding in rats trained in a fixed-ratio 10, food-reinforced 10-min procedure. Pretreatment with SR141716A either had no effect on (at 0.3-1 mg/kg), or partially blocked (at 3 mg/kg), the inhibitory effects on responding induced by Delta(9)-THC (3-5 mg/kg) and CP 55,940 (0.03-0.2 mg/kg). Interestingly, while 3 mg/kg SR141716A induced moderate inhibitory effects on operant responding, its combination with either agonist resulted in the same level of inhibitory activity on responding as that obtained by SR141716A when tested alone. Pretreatment with a low dose of CP 55,940 (0.01 mg/kg) or WIN 55,212-2 (0.3 mg/kg) did not affect response inhibition induced by SR141716A. Combination of SR141716A (0.5 and 1 mg/kg) with Delta(9)-THC (3 mg/kg) resulted in the same level of response inhibition, independently of whether SR141716A was given 5 min before or 15 min after Delta(9)-THC. Although alternative explanations are conceivable, the data may indicate that SR141716A is a partial agonist at those cannabinoid receptors mediating the response-rate suppressive effects of cannabinoids.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 26 条
[1]  
Breivogel CS, 2000, J PHARMACOL EXP THER, V295, P328
[2]   A detailed characterization of the effects of four cannabinoid agonists on operant lever pressing [J].
Carriero, D ;
Aberman, J ;
Lin, SY ;
Hill, A ;
Makriyannis, A ;
Salamone, JD .
PSYCHOPHARMACOLOGY, 1998, 137 (02) :147-156
[3]  
COMPTON DR, 1992, J PHARMACOL EXP THER, V263, P1118
[4]   Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development [J].
De Vry, J ;
Jentzsch, KR ;
Kuhl, E ;
Eckel, G .
BEHAVIOURAL PHARMACOLOGY, 2004, 15 (01) :1-12
[5]   Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A [J].
De Vry, J ;
Schreiber, R ;
Eckel, G ;
Jentzsch, KR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 483 (01) :55-63
[6]   Effects of serotonin 5-HT1/2 receptor agonists in a limited-access operant food intake paradigm in the rat [J].
De Vry, J ;
Schreiber, R ;
Daschke, A ;
Jentzsch, KR .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 (05) :337-345
[7]   Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm [J].
De Vry, J ;
Jentzsch, KR .
BEHAVIOURAL PHARMACOLOGY, 2003, 14 (5-6) :471-476
[8]   Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist [J].
De Vry, J ;
Jentzsch, KR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 457 (2-3) :147-152
[9]   Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding [J].
Freedland, CS ;
Poston, JS ;
Porrino, LJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2000, 67 (02) :265-270
[10]   ISOLATION, STRUCTURE, AND PARTIAL SYNTHESIS OF AN ACTIVE CONSTITUENT OF HASHISH [J].
GAONI, Y ;
MECHOULAM, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (08) :1646-+